Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Middle Tennessee Research Institute (MTRI) is a non-profit clinical research organization and site management entity based in Nashville, Tennessee. The institute specializes in facilitating Phase I through IV clinical trials, with a primary focus on cardiovascular medicine, oncology, and infectious diseases. MTRI serves as the research arm for Ascension Saint Thomas, collaborating with global pharmaceutical sponsors and medical device manufacturers to execute high-quality clinical studies. By integrating research into the clinical care setting, the organization provides patients with access to innovative therapies and contributes to the advancement of evidence-based medical practices. MTRI is recognized for its robust data management capabilities and its commitment to maintaining high regulatory standards in clinical investigation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Middle Tennessee Research Institute.